Funding for this research was provided by:
National Natural Science Foundation of China (81941017, 81770842, 81970728, 81970706, 81870560)
National Key R&D Program of China (2018YFC1311705, 2016YFC1304904, 2016YFC1305600)
Clinical Research Plan of SHDC (SHDC2020CR1001A, SHDC2020CR3069B)
Shanghai Municipal Education Commission–Gaofeng Clinical Medicine Grant Support (20161307)
Shanghai Municipal Education Commission–Gaofeng Clinical Medicine Grant Support (20152508 Round 2)
Received: 9 June 2021
Accepted: 19 November 2021
First Online: 7 December 2021
: The study protocol was approved by the Institutional Review Board of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki declaration of 1975, as revised in 1983. Written informed consent was obtained from each study participant.
: Not applicable.
: The authors declare that they have no competing interests.